Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Muscarinic M3-selective antagonists designed at Banyu

April 5, 2001

Sch-62373, a dual NK1/NK2 antagonist from a series of 2-phenylpiperazines

April 5, 2001

Cell adhesion inhibitors identified by Merck group

April 4, 2001

Sepracor submits sNDA to FDA for pediatric use of Xopenex

April 4, 2001

Cinnamide-based LFA-1/ICAM-1 antagonists with improved properties presented at ACS meeting

April 3, 2001

Nonpeptide inhibitors of VLA-4-mediated cell adhesion emerge from R&D at Biogen

April 2, 2001

Oxeze Turbuhaler approved in Canada for control and relief of asthma symptoms

March 30, 2001

Tryptase inhibitors and use in respiratory disorders claimed by Byk Gulden

March 29, 2001

Ciclesonide to be codeveloped and copromoted by Aventis and Altana for asthma

March 29, 2001

MoliChem's aerosol product for CF undergoes phase Ib clinical trials

March 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...